Sarami I, Duffield AS, Sundaram S, Lin DI, Salib C, Hussein S, El Jamal S, Ghesani N, Cangut B, Petersen BE. An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2849-54. Available from: https://haematologica.org/article/view/12133